Dr. Amandeep Kaur Cheema

Dentist



  
  903 S Ashland Ave Apt 1217b, Chicago
  Illinois, 60607-4193

  248-703-6838    Maps & Directions
Dr. Amandeep Kaur Cheema is a Chicago, Illinois based Dentist who is specialized in Dentistry. She may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. Her current practice location is 903 S Ashland Ave Apt 1217b, Chicago. Patients can reach her at 248-703-6838.
Dr. Amandeep Kaur Cheema is the primary dental care provider for patients of all ages. She is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Amandeep Kaur Cheema speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Amandeep Kaur Cheema
Specialization: Dentist
Gender:Female
Accepts Medicare Assignment:May Accept
Practice Address:903 S Ashland Ave Apt 1217b, Chicago,
Illinois, 60607-4193
Phone:248-703-6838
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 0547527269
Enrollment ID: I20171205000181
NPI Number: 1881106854
NPI Enumeration Date: 31 Oct, 2017
NPI Last Update On: 31 Oct, 2017

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 903 S Ashland Ave Apt 1217b,
Chicago, Illinois
Zip: 60607-4193
Phone Number: 248-703-6838
Patients can reach Dr. Amandeep Kaur Cheema at 903 S Ashland Ave Apt 1217b, Chicago, Illinois or can call to book an appointment on 248-703-6838. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: